<DOC>
	<DOCNO>NCT02323373</DOCNO>
	<brief_summary>This clinical trial investigate two different route administration tranexamic acid total knee arthroplasty : topical compare intravenous .</brief_summary>
	<brief_title>Topical Versus Intravenous Tranexamic Acid Total Knee Arthroplasty</brief_title>
	<detailed_description>Intravenous administration tranexamic acid ( TA ) common orthopedic surgery . The ideal dose administration route drug total knee arthroplasty ( TKA ) investigation . The objective randomized clinical trial verify difference topical intravenous administration TA TKA regard blood loss coagulation variable . Patients undergo TKA randomize receive TA intravenously ( 20 mg 100 ml saline ) , topically ( 1.5 g 50 ml saline , spray operate site , closure ) intravenous saline ( 100 ml ) . Suction drain maintain 48 hour , order measure blood loss . Data analysis undertaken , order compare two route administration drug .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<mesh_term>Antifibrinolytic Agents</mesh_term>
	<criteria>Patients need unilateral total knee arthroplasty ( TKA ) due arthrosis , Albach grade III IV eligible history identify risk deep vein thrombosis pulmonary embolism history coagulation cardiovascular disorder vascular disease pregnancy current use anticoagulation drug previous orthopedic surgery leg .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Arthroplasty , Replacement , Knee</keyword>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Drug Administration Routes</keyword>
</DOC>